Return On Equity in % of Neuphoria Therapeutics Inc. from 2024 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neuphoria Therapeutics Inc. quarterly/annual Return On Equity history and change rate from 2024 to Q3 2025.
  • Neuphoria Therapeutics Inc. Return On Equity for the quarter ending 30 Sep 2025 was 0 %, a 11.3% increase year-over-year.
  • Neuphoria Therapeutics Inc. annual Return On Equity for 2025 was 0 %, a 97.5% increase from 2024.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Neuphoria Therapeutics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 0 +0 +11.3% 01 Jul 2025 30 Sep 2025
Q2 2025 0 +1 +97.5% 01 Apr 2025 30 Jun 2025
Q1 2025 0 01 Jan 2025 31 Mar 2025
Q4 2024 0 01 Oct 2024 31 Dec 2024
Q3 2024 0 01 Jul 2024 30 Sep 2024
Q2 2024 0 01 Apr 2024 30 Jun 2024

Neuphoria Therapeutics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 0 +1 +97.5% 01 Jul 2024 30 Jun 2025
2024 0 01 Jul 2023 30 Jun 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.